Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Lisuride, sold under the brand name Dopergin among others, is a monoaminergic medication of the ergoline family which is used in the treatment of Parkinson's disease, migraine, and high prolactin levels. It is taken by mouth.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Lisuride. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
5-ht2a serotonin receptor effects receptors dopamine lsd agonist may parkinson's disease side prolactin doses treatment psychedelic hallucinogenic antagonist high levels
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Lisuride | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Lisuride | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Lisuride | ATC code | G02CB02 (WHO) N02CA07 (WHO) | 1.00 | infobox |
| Lisuride | Bioavailability | 10–20% | 1.00 | infobox |
| Lisuride | CAS Number | 18016-80-3 Y | 1.00 | infobox |
| Lisuride | ChEBI | CHEBI:51164 Y | 1.00 | infobox |
| Lisuride | ChEMBL | ChEMBL157138 Y | 1.00 | infobox |
| Lisuride | ChemSpider | 26847 Y | 1.00 | infobox |
| Lisuride | CompTox Dashboard (EPA) | DTXSID30274075 DTXSID3023217, DTXSID30274075 | 1.00 | infobox |
| Lisuride | Drug class | Serotonin receptor agonist; Dopamine receptor agonist | 1.00 | infobox |
| Lisuride | DrugBank | DB00589 Y | 1.00 | infobox |
| Lisuride | ECHA InfoCard | 100.038.099 | 1.00 | infobox |
| Lisuride | Elimination half-life | 2 hours | 1.00 | infobox |
| Lisuride | Excretion | Renal and biliary in equal amounts | 1.00 | infobox |
| Lisuride | Formula | C20H26N4O | 1.00 | infobox |
| Lisuride | IUPHAR/BPS | 43 | 1.00 | infobox |
| Lisuride | KEGG | D08132 Y | 1.00 | infobox |
| Lisuride | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Lisuride | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Lisuride | Metabolism | Hepatic | 1.00 | infobox |
| Lisuride | Metabolites | More than 15 known | 1.00 | infobox |
| Lisuride | Molar mass | 338.455 g·mol−1 | 1.00 | infobox |
| Lisuride | Other names | Lysuride; Mesorgydin; Methylergol carbamide; 1,1-Diethyl-3-(6-methyl-9,10-didehydroergolin-8α-yl)urea | 1.00 | infobox |
| Lisuride | Protein binding | 60–70% | 1.00 | infobox |
| Lisuride | PubChem CID | 28864 | 1.00 | infobox |
| Lisuride | Routes of administration | Oral Investigational: Subcutaneous implant, transdermal patch | 1.00 | infobox |
| Lisuride | Trade names | Dopergin, others | 1.00 | infobox |
| Lisuride | UNII | E0QN3D755O | 1.00 | infobox |
| Lisuride | is a | partial agonist of the D2 | 0.90 | text |
| Lisuride | is a | extremely potent serotonin 5-HT1A receptor agonist | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.